- Home
- IRBT vs TIL Comparison
IRBT vs TIL Comparison
Compare IRBT & TIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRBT
- TIL
- Stock Information
- Founded
- IRBT 1990
- TIL 2018
- Country
- IRBT United States
- TIL United States
- Employees
- IRBT N/A
- TIL N/A
- Industry
- IRBT Consumer Electronics/Appliances
- TIL Biotechnology: Pharmaceutical Preparations
- Sector
- IRBT Consumer Discretionary
- TIL Health Care
- Exchange
- IRBT Nasdaq
- TIL Nasdaq
- Market Cap
- IRBT 168.4M
- TIL 177.1M
- IPO Year
- IRBT N/A
- TIL 2021
- Fundamental
- Price
- IRBT $4.63
- TIL $19.34
- Analyst Decision
- IRBT Hold
- TIL Strong Buy
- Analyst Count
- IRBT 1
- TIL 5
- Target Price
- IRBT N/A
- TIL $100.67
- AVG Volume (30 Days)
- IRBT 3.2M
- TIL 141.9K
- Earning Date
- IRBT 11-04-2025
- TIL 11-12-2025
- Dividend Yield
- IRBT N/A
- TIL N/A
- EPS Growth
- IRBT N/A
- TIL N/A
- EPS
- IRBT N/A
- TIL N/A
- Revenue
- IRBT $594,601,000.00
- TIL N/A
- Revenue This Year
- IRBT N/A
- TIL N/A
- Revenue Next Year
- IRBT $69.39
- TIL N/A
- P/E Ratio
- IRBT N/A
- TIL N/A
- Revenue Growth
- IRBT N/A
- TIL N/A
- 52 Week Low
- IRBT $1.76
- TIL $10.80
- 52 Week High
- IRBT $13.06
- TIL $44.50
- Technical
- Relative Strength Index (RSI)
- IRBT 57.47
- TIL 47.90
- Support Level
- IRBT $4.36
- TIL $18.05
- Resistance Level
- IRBT $6.10
- TIL $21.64
- Average True Range (ATR)
- IRBT 0.53
- TIL 1.55
- MACD
- IRBT 0.07
- TIL 0.40
- Stochastic Oscillator
- IRBT 42.72
- TIL 56.18
About IRBT iRobot Corporation
iRobot Corp is a United state based consumer robot company. It designs and builds robots that assist consumers with the solutions for the activities to be carried out both inside and outside of the home. The company's consumer robot comprises a portfolio of solutions which includes cleaning, mapping and navigation, human-robot interaction, and physical solutions. The company operates in the business segment of Consumer robots. The consumer robot products are provided to the consumers by retail businesses and online stores. The company derives its revenue from the product sales. It sells the products across the United States and around the world.
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.